Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
Popat R, Lonial S, Voorhees PM, Esposti SD, Gorsh B, Gupta I, Opalinska J, Sapra S, Piontek T, He Z, Kleinman D, Schaumberg D, Regnault A, Meunier J, Eliason L. Popat R, et al. Among authors: esposti sd. J Adv Pract Oncol. 2023 Sep;14(6):503-518. doi: 10.6004/jadpro.2023.14.6.4. Epub 2023 Sep 1. J Adv Pract Oncol. 2023. PMID: 37808071 Free PMC article.
Paracentral acute middle maculopathy following COVID-19.
Gameiro Filho AR, Godoy R, Rees A, Esposti SD. Gameiro Filho AR, et al. Among authors: esposti sd. Arq Bras Oftalmol. 2023 Jul-Aug;86(4):397-399. doi: 10.5935/0004-2749.2023-0064. Arq Bras Oftalmol. 2023. PMID: 37466496 Free article. No abstract available.
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Khwaja J, Bomsztyk J, Mahmood S, Wisniowski B, Shah R, Tailor A, Yong K, Popat R, Rabin N, Kyriakou C, Sive J, Esposti SD, Larkin DFP, Worthington S, Hart A, Dowling E, Correia N, Bygrave C, Rydzewski A, Jamroziak K, Wechalekar AD. Khwaja J, et al. Among authors: esposti sd. Blood Cancer J. 2022 Sep 5;12(9):128. doi: 10.1038/s41408-022-00717-2. Blood Cancer J. 2022. PMID: 36064540 Free PMC article. No abstract available.
Partial recovery of visual function in a blind patient after optogenetic therapy.
Sahel JA, Boulanger-Scemama E, Pagot C, Arleo A, Galluppi F, Martel JN, Esposti SD, Delaux A, de Saint Aubert JB, de Montleau C, Gutman E, Audo I, Duebel J, Picaud S, Dalkara D, Blouin L, Taiel M, Roska B. Sahel JA, et al. Among authors: esposti sd. Nat Med. 2021 Jul;27(7):1223-1229. doi: 10.1038/s41591-021-01351-4. Epub 2021 May 24. Nat Med. 2021. PMID: 34031601
Panel-based genetic testing for inherited retinal disease screening 176 genes.
Sheck LHN, Esposti SD, Mahroo OA, Arno G, Pontikos N, Wright G, Webster AR, Khan KN, Michaelides M. Sheck LHN, et al. Among authors: esposti sd. Mol Genet Genomic Med. 2021 Dec;9(12):e1663. doi: 10.1002/mgg3.1663. Epub 2021 Mar 22. Mol Genet Genomic Med. 2021. PMID: 33749171 Free PMC article.
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis.
Agrawal R, Betzler BK, Testi I, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, McCluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham ET, Kempen JH, Nguyen QD, Pavesio C, Gupta V. Agrawal R, et al. Among authors: esposti sd. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):27-37. doi: 10.1080/09273948.2020.1808226. Epub 2020 Nov 17. Ocul Immunol Inflamm. 2020. PMID: 33200957
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population.
Testi I, Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, Mccluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham ET, Kempen JH, Nguyen QD, Pavesio C, Gupta V. Testi I, et al. Among authors: esposti sd. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):58-64. doi: 10.1080/09273948.2020.1781197. Epub 2020 Aug 17. Ocul Immunol Inflamm. 2020. PMID: 32804578
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6.
Agrawal R MD, FCRS, Gunasekeran DV MBBS, Agarwal A MS, Testi I MD, Carreño E MD, Westcott M FRCOphth, Mahajan S MBBS, Raje D PhD, Aggarwal K MS, Murthy SI DNB, Chee SP FRCSEd, Mccluskey P MD, Ho SL FRCSGlasg, Teoh S FRCSEd, Cimino L MD, Biswas J MS, Narain S MD, Agarwal M MS, Mahendradas P DNB, Khairallah M MD, Jones N FRCSOphth, Tugal-Tutkun I MD, Babu K DNB, Basu S MS, Lee R PhD, Al-Dhibi H MD, Bodaghi B MD, Invernizzi A MD, Goldstein DA MD, Herbort CP MD, Barisani-Asenbauer T PhD, González-López JJ PhD, Androudi S MD, Bansal R MS, Moharana B MS, Esposti SD MD, Tasiopoulou A MD, Nadarajah S MD, Agarwal M DNB, Abraham S MD, Vala R MD, Singh R MS, Sharma A MD, Sharma K PhD, Zierhut M PhD, Kon OM MRCP, Cunningham ET PhD, Kempen JH PhD, Nguyen QD PhD, Pavesio C FRCSOphth, Gupta V MS. Agrawal R MD, FCRS, et al. Among authors: esposti sd md. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):49-57. doi: 10.1080/09273948.2020.1774905. Epub 2020 Jun 30. Ocul Immunol Inflamm. 2020. PMID: 32600169
34 results